Keira Knightley leaves behind blockbusters

Hollywood heavyweight Keira Knightley has admitted to putting big-budget blockbusters on the backburner, as they tend to “make life rather tricky”.

Currently doing the rounds at the Toronto International Film Festival, Knightley is promoting her upcoming historical drama A Dangerous Method which has already generated some major Oscar-buzz.

The World War I drama focuses on the raging relationship between pioneering psychoanalysts Carl Jung and Sigmund Freud, with Knightley portraying the Russian patient Sabrina Spielrein who comes between the pair.

The 26-year-old star’s much acclaimed performance in David Cronenberg latest drama may see her land her second Academy Award nomination, but the intense role took some real research. Talking exclusively to E! News, Knightley admitted that it took four months of reading to prepare for the role of Sabrina. She also added “With a character like this one, it is so far away from me fortunately, so it was really about building her from the ground up.”

While the Pirates of the Caribbean franchise brought the actress phenomenal box-office success so early on in her career, she admits she made a “conscious decision” to move away from such roles. Although she admits she was extremely lucky to land those parts, she says “It did make life rather tricky, just getting out of the front door.”

A Dangerous Method is scheduled for a November 2011 release.

About The Author

Manleen is currently studying Journalism (BA) at London’s elite City University. As an avid movie fanatic, she is combining the skills taught within her degree to kick-start her career as a movie critic. She’s worked with some media heavyweights in the past, such as the BBC, CNN and Orange Film Club. Manleen has joined the team and takes on the role of news and reviews writer and social media promoter.

One Response

  1. Jane

    I do hope she’ll earned her second Oscar nomination for this work. She’s so talented.


Leave a Reply

Your email address will not be published.